• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    logo
    Britannia Industries Ltd.
    12 Nov 2022
    6209.50
    -0.04%
    Buy Britannia Industries; target of Rs 4780: Sharekhan
    Buy Britannia Industries; target of Rs 4780: Sharekhan
    Moneycontrol
    Sharekhan is bullish on Britannia Industries has recommended buy rating on the stock with a target price of Rs 4780 in its research report dated November 07, 2022.
    Copy LinkShare onShare on Share on Share on
    Britannia Industries Ltd. has gained 17.11% in the last 1 Month
    logo
    Zydus Wellness Ltd.
    11 Nov 2022
    Split 10-year high
    2617.40
    2.82%
    Zydus Lifesciences Q2 net profit falls to Rs 522.5 crore
    Zydus Lifesciences Q2 net profit falls to Rs 522.5 crore
    Moneycontrol
    Sharvil Patel, Managing Director, Zydus Lifesciences Limited, said: "Our Q2 FY23 performance reflects strong execution in our key businesses, sustaining growth momentum and profitability."
    Copy LinkShare onShare on Share on Share on
    Sharekhan increased Buy price target of Zydus Wellness Ltd. to 2688.0 on 03 Sep, 2025.
    Zydus Lifesciences standalone Q2 net at Rs 451 crore
    Business Line | 11 Nov 2022 3 more
    Zydus Lifesciences Q2 net profit down 82.6% to Rs 523 cr on rising costs
    Business Standard | 11 Nov 2022
    Zydus Wellness Consolidated September 2022 Net Sales at Rs 429.47 crore, up 11.94% Y-o-Y
    Moneycontrol | 11 Nov 2022
    Zydus Wellness reports 14 crore profit in Q2
    Business Line | 10 Nov 2022
    logo
    Vadilal Industries Ltd.
    11 Nov 2022
    5682.00
    -1.78%
    Vadilal Ind Standalone September 2022 Net Sales at Rs 227.77 crore, up 55.33% Y-o-Y
    Vadilal Ind Standalone September 2022 Net Sales at Rs 227.77 crore, up 55.33% Y-o-Y
    Moneycontrol
    NULL
    Copy LinkShare onShare on Share on Share on
    Vadilal Industries Ltd. has gained 10.33% in the last 1 Week
    F
    Future Consumer Ltd.
    11 Nov 2022
    Future Consumer Standalone September 2022 Net Sales at Rs 17.73 crore, down 94.42% Y-o-Y
    Future Consumer Standalone September 2022 Net Sales at Rs 17.73 crore, down 94.42% Y-o-Y
    Moneycontrol
    NULL
    Copy LinkShare onShare on Share on Share on
    Future Consumer Ltd. is trading below all available SMAs
    logo
    Britannia Industries Ltd.
    11 Nov 2022
    6209.50
    -0.04%
    Neutral Britannia Industries; target of Rs 4210: Motilal Oswal
    Neutral Britannia Industries; target of Rs 4210: Motilal Oswal
    Moneycontrol
    Motilal Oswal recommended Neutral rating on Britannia Industries with a target price of Rs 4210 in its research report dated November 07, 2022.
    Copy LinkShare onShare on Share on Share on
    Britannia Industries Ltd. has gained 17.11% in the last 1 Month
    logo
    ADF Foods Ltd.
    09 Nov 2022
    230.66
    -0.51%
    ADF Foods Consolidated September 2022 Net Sales at Rs 106.74 crore, down 2.42% Y-o-Y
    ADF Foods Consolidated September 2022 Net Sales at Rs 106.74 crore, down 2.42% Y-o-Y
    Moneycontrol
    NULL
    Copy LinkShare onShare on Share on Share on
    ADF Foods Ltd. is trading below its 50 day SMA of 243.5
    logo
    Zydus Wellness Ltd.
    08 Nov 2022
    Split 10-year high
    2617.40
    2.82%
    USFDA approves Zydus Lifesciences' generic hypertension drug
    USFDA approves Zydus Lifesciences' generic hypertension drug
    livemint
    Zydus Lifesciences' generic hypertension drug, Bisoprolol Fumarate and Hydrochlorothiazide, received approval from USFDA
    Copy LinkShare onShare on Share on Share on
    Zydus Wellness Ltd. has gained 64.51% in the last 6 Months
    Zydus Lifesciences gets USFDA nod for generic hypertension drug
    Moneycontrol | 08 Nov 2022
    logo
    Britannia Industries Ltd.
    08 Nov 2022
    6209.50
    -0.04%
    An encore of Q2 show can take Britannia's stock to greater heights
    An encore of Q2 show can take Britannia's stock to greater heights
    Economic Times
    Analysts have reason to be positive on Britannia. If the company can continue the growth momentum of the September quarter, it is likely to perform strongly over the next few quarters. However, it may become difficult if the overall consumer demand slows down further.
    Copy LinkShare onShare on Share on Share on
    Britannia Industries Ltd. has gained 31.33% in the last 6 Months
    logo
    Britannia Industries Ltd.
    07 Nov 2022
    6209.50
    -0.04%
    Britannia Sep quarter: With good pricing, come good results
    Britannia Sep quarter: With good pricing, come good results
    livemint
    Britannia delivered on margin improvement one quarter ahead, largely helped by a gutsy 17% year-on-year (y-o-y) pricing growth, which translates to an incremental in-quarter price-hike of 9-10%, pointed out analysts from JM Financial Institutional Securities
    Copy LinkShare onShare on Share on Share on
    Britannia Industries.. has an average target of 5824.71 from 7 brokers.
    Britannia Industries Breaks Into Rs 1 Lakh Crore Market Cap Club
    NDTV Profit | 07 Nov 2022 7 more
    Broker's Call: Britannia Industries (Hold)
    Business Line | 07 Nov 2022
    Britannia stock jumps 10%; NSE H1FY23 consolidated PAT jumps 53%
    Business Standard | 07 Nov 2022
    Britannia shares scale fresh high as Q2 earnings surpass expectations
    livemint | 07 Nov 2022
    Britannia Industries' shares jump nearly 10% after Q2 profit beat
    Business Standard | 07 Nov 2022
    Britannia shares jump 10% to record high as Q2 results beat estimates. Should you buy?
    livemint | 07 Nov 2022
    Britannia surges 9% on healthy Q2, market cap hits Rs 1 lakh crore; should you buy, sell or …
    Moneycontrol | 07 Nov 2022
    Britannia zooms 10% on robust Q2 revenue growth; enters Rs 1 trn m-cap club
    Business Standard | 07 Nov 2022
    logo
    Zydus Wellness Ltd.
    07 Nov 2022
    Split 10-year high
    2617.40
    2.82%
    Zydus gets establishment inspection report from USFDA for Moraiya plant
    Zydus gets establishment inspection report from USFDA for Moraiya plant
    Business Standard
    Zydus Lifesciences on Monday said it has received an establishment inspection report from the US health regulator for its formulations manufacturing facility in Moraiya near Ahmedabad. The US Food and Drug Administration (USFDA) inspected the facility from July 26 to August 5, 2022, which concluded with four observations. "The USFDA has determined that the inspection classification of the facility is Voluntary Action Indicated (VAI)," it added. The USFDA issues an establishment inspection report (EIR) to an establishment that is the subject of an FDA or FDA-contracted inspection when the agency decides to close the inspection. Shares of Zydus Lifesciences were trading 2.51 per cent up at Rs 450.85 apiece on the BSE.
    Copy LinkShare onShare on Share on Share on
    Zydus Wellness Ltd. has an average target of 1987.00 from 4 brokers.
    Zydus gets EIR from USFDA for Moraiya plant
    Moneycontrol | 07 Nov 2022 1 more
    Zydus receives EIR from USFDA for Moraiya plant
    Business Line | 07 Nov 2022
    more
    loading
    Trendlyne Logo Trendlyne
    Stay ahead of the market
    Markets Today
    • Nifty 50 today
    • Sensex today
    • Latest Quarterly results
    • FII & DII data today
    Dashboard
    • Industry & Sector analysis
    • ETFs
    • Mutual Funds
    • Bullish & Bearish spread
    • Global Indices
    Tools
    • Compare stocks
    • Widgets
    • Data Downloader
    • Excel Connect
    IPOs
    • Dashboard (Mainboard & SME)
    • Upcoming IPOs
    • Recently Listed IPOs
    • Most Successful IPOs
    Upcoming IPOs
    • TechD Cybersecurity
    • L T Elevator
    • Euro Pratik Sales
    Quick Links
    • Contact us
    • Blogs
    • FAQs
    Company
    • Privacy
    • Terms of Use
    • Disclaimer
    Trendlyne Products
    • Starfolio
    • SmartOptions
    • Trendlyne US Global
    Get Mobile App
    • Android
    • iOS

    Copyright © 2025 Giskard Datatech Pvt Ltd